Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Start date: May 18, 2025 End date: May 18, 2025
Radcliffe Medical Education is hosting a symposium entitled 'Addressing the Challenges in Cardiorenal Patient Care' at theHeart Failure Association (HFA)in Belgrade (RS) on Sunday 18 May 2025 at 12:30–13:30 CEST.OverviewIn this symposium, join Dr Kieran Docherty (Glasgow, UK), Prof Clara Saldarriaga (Medellin, CO) and Prof Gianluigi Savarese (Stockholm, SE) as they explore the complexities of… View more
Author(s): Michelle Kittleson Added: 1 year ago
AHA Conference 2024 - In this highlights video from AHA 2024, Dr Michelle Kittleson (Cedars-Sinai California Heart Center, US) offers a concise and insightful summary of the most influential late-breaking trials presented at the conference. Dr Kittleson discusses the pivotal studies poised to impact clinical practice and enhance patient outcomes in heart failure care.Trials covered in detail… View more
Job title: The Kenneth Jay Pollin Professor of Cardiology, Professor of Medicine
Dr Roger S. Blumenthal is The Kenneth Jay Pollin Professor of Cardiology, Professor of Medicine and the Director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease in Baltimore, Maryland, US. Dr Blumenthal graduated with honors from the Landon School in Bethesda and the Johns Hopkins University. He received his medical degree from Cornell Medical College, where he… View more
Author(s): James Burton Added: 1 year ago
Chaired by Prof James Burton (University of Leicester, UK), this roundtable features expert insight from a world-renowned faculty, Prof David Wheeler (University College London, UK) and Dr Navdeep Tangri (University of Manitoba, CA).Dr Tangri begins by providing an overview of the recent KDIGO guideline updates. Following this, the panel recap on the patient case that was presented in part one of… View more
Added: 1 year ago Source:  Radcliffe CVRM
A recent study published in Circulation: Heart Failure1 has found that multimorbidity, the presence of two or more chronic health conditions, substantially increases the risk of mortality in patients with heart failure who have mildly reduced (HFmrEF) or preserved ejection fraction (HFpEF).The study analyzed data from two major heart failure trials: TOPCAT-Americas (Treatment of Preserved Cardiac… View more
Author(s): Harriette Van Spall , Mikhail Kosiborod Added: 1 year ago
AHA Conference 2024 — REALIZE-K: Impact of sodium zirconium cyclosilicate (SZC) on HFrEF patient's potassium levels whilst on spironolactone.Late-Breaker Host, Dr Harriette Van Spall (McMaster University, CA) is joined onsite by Dr Mikhail Kosiborod (Saint Luke's Mid America Heart Institute, US) to discuss the findings from the REALIZE-K Study (NCT04676646; AstraZeneca).REALIZE-K is a phase 4… View more
Author(s): Felipe Martínez Added: 2 weeks ago
ACC.26 - In this expert interview filmed at ACC.26 in New Orleans, Prof. Felipe Martínez discusses how late-breaking heart failure data are reshaping contemporary pharmacological management. The conversation focuses on new spironolactone results, advanced hemodynamic strategies in HFpEF, and the expanding role of cardiometabolic therapies, including GLP‑1 receptor agonists, in optimising outcomes… View more